Sign up to save your podcasts
Or
Share Amer Zeidan, MBBS, MHS, on the Evolution of AML Classification, Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amer Zeidan, MBBS, MHS, on the Evolution of AML Classification, Treatment
In this episode of The HemOnc Pulse, Amer Zeidan, MBBS, MHS, of Yale, discusses the impact of AML classification updates, the practical implications of testing for genetic alterations, and how patient characteristics inform his approach to treating AML, with host Chadi Nabhan, MD, MBA, FACP.
View all episodes
By Rahul Banerjee, MD
4.8
2727 ratings
In this episode of The HemOnc Pulse, Amer Zeidan, MBBS, MHS, of Yale, discusses the impact of AML classification updates, the practical implications of testing for genetic alterations, and how patient characteristics inform his approach to treating AML, with host Chadi Nabhan, MD, MBA, FACP.